David A. Siegel Forte Biosciences, Inc. Put Options Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding FBRX
# of Institutions
34Shares Held
19MCall Options Held
1KPut Options Held
0-
Tybourne Capital Management (Hk) LTD Hong Kong, K33.62MShares$2.07 Million0.57% of portfolio
-
Perceptive Advisors LLC New York, NY3.27MShares$1.86 Million0.05% of portfolio
-
Bvf Inc San Francisco, CA2.98MShares$1.7 Million0.06% of portfolio
-
Cable Car Capital LLC San Francisco, CA2.03MShares$1.16 Million1.95% of portfolio
-
Fred Alger Management, LLC New York, NY1.84MShares$1.05 Million0.01% of portfolio
About Forte Biosciences, Inc.
- Ticker FBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,340,300
- Market Cap $11.6M
- Description
- Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.